SHANGHAI, China, March 31 /Xinhua-PRNewswire/ -- WuXi PharmaTech, the
leading pharmaceutical, biotechnology and medical device R&D outsourcing
company with operations in China and the United States, was very honored to
have Professor David W. C. MacMillan, a renowned researcher from Princeton
University, as a WuXi PharmaTech Science Seminar Series speaker who
delivered a lecture to the company's young scientists on March 25, 2008.
(Logo: http://www.newscom.com/cgi-bin/prnh/20040705/CNM002LOGO )
Aiming to keep the company's young scientists abreast of the latest
drug R&D knowledge and technologies, the WuXi PharmaTech Science Seminar
Series is a monthly program that invites accomplished researchers from
academia and the industry to share their wealth of experience and expertise
with the company's scientists.
Dr. David MacMillan obtained his undergraduate degree from Glasgow
University, and in 1990 moved to the University of California, Irvine,
where he obtained his Ph.D. under the direction of Larry E. Overman.
Following postdoctoral research with David A. Evans at Harvard University,
Dr. MacMillan began his independent research career at the University of
California, Berkeley, in 1998. In 2000, he joined the department of
chemistry at Caltech, and was promoted to full professor in 2003. He was
appointed to the A. Barton Hepbum Chair of Chemistry and Director of the
Merck Center for Catalysis at Princeton University in June 2006.
Dr. MacMillan is a leader in the currently active area of asymmetric
organocatalysis. His numerous accomplishments have found widespread
industrial application and his success is evidenced by the numerous awards
and honors he has received from professional associations like the Royal
Society of Chemistry, the American Chemical Society and the industry.
"We are very honored and privileged to have Dr. MacMillan as one of our
seminar speakers. His remarkable achievements in the field of organic
synthesis will motivate our young scientists," said Dr. Shuhui Chen, Chief
Scientific Officer of the company. "As a research-driven company serving
global pharmaceutical, biotechnology and medical device companies, we
believe science has no boundary. We will continue inviting heavy-weight
speakers to WuXi so that our scientists can learn from the best, and
ultimately provide better services to our customers."
About WuXi PharmaTech
WuXi PharmaTech, headquartered in Shanghai, China, is a leading global
pharmaceutical, biotechnology and medical device R&D outsourcing company
with operations in China and the U.S. As a research-driven and
customer-focused company, WuXi PharmaTech provides a broad and integrated
portfolio of laboratory and manufacturing services throughout the drug and
medical device R&D process to pharmaceutical, biotechnology and medical
device companies. Our services are designed to assist our global customers
in shortening the time and lowering the cost of drug and medical device R&D
by providing cost- effective and efficient outsourcing solutions. For more
information, please visit: http://www.wuxipharmatech.com .
For more information, please contact:
SOURCE WuXi PharmaTech